Healthtech Startups
17,202 companies tagged Healthtech, with their investors and founders.
0 investors
0 investors
0 investors
Imago Systems develops Visual Intelligence (VI) image classification technology that processes medical images and converts unstructured image content into structured data for detection and diagnosis. It targets healthcare imaging verticals including mammography, cardiology image analysis, COVID-19 X-ray/ultrasound analysis, contract research organizations, and animal diagnostics, positioning itself as a processing layer for existing imaging equipment and AI systems.
0 investors
Imanis Life Sciences is a contract research organization staffed by virologists, immunologists, molecular biologists, and assay scientists that provides laboratory and development services to help clients accelerate therapy development.
0 investors
0 investors
0 investors
0 investors
ImmersiveTouch develops a virtual reality platform that converts patient CT and MRI scan data into interactive 3D simulations of individual patient anatomy for clinicians. The company serves surgeons and healthcare providers with tools for surgical planning, simulation, and training in support of personalized medicine.
0 investors
Immunaeon provides cellular banking and cryopreservation services, helping individuals preserve their healthiest cells for potential future medical use. The company serves patients seeking to maintain medical options through cell preservation, with an emphasis on clear communication and privacy protection.
0 investors
Immuneering develops Deep Cyclic Inhibitors, a class of oncology medicines designed to pulse dosing faster than cancer's adaptive mechanisms to limit resistance and reduce side effects. The company targets more durable tumor control and improved tolerability for cancer patients.
0 investors
ImmuneSensor Therapeutics is a clinical-stage biotechnology company developing orally available small molecule cGAS inhibitors that target the cGAS-STING innate immune pathway to treat inflammatory and autoimmune diseases. Founded on research from UT Southwestern Medical Center, it advances a pipeline of drug candidates for immune-related conditions.
0 investors
0 investors
ImmunoMet Therapeutics is a clinical-stage oncology drug developer working to advance lixumistat, a compound targeting oxidative phosphorylation in cancer to address resistance to existing treatments. Founded in 2015 as a spin-off from HanAll Biopharma, the company runs its clinical programs with specialist CROs and partners, including trials at MD Anderson Cancer Center.
0 investors
0 investors
0 investors
ImmusanT works on scientific research into the mechanisms of celiac disease, collaborating with investigators from academic and medical research institutions. The company operates in the biotechnology and immunology field focused on this autoimmune condition.
0 investors
0 investors
0 investors
0 investors
0 investors
Imricor develops MRI-guided cardiac electrophysiology products, including the Vision-MR ablation and diagnostic catheters, the NorthStar Mapping System, and the Advantage-MR EP Recorder/Stimulator, used to perform catheter ablation procedures under real-time MRI. The company's devices are targeted at cardiac electrophysiology labs, with several products holding CE mark and some FDA clearance.
0 investors
0 investors
Imunon develops DNA-based immunology technologies designed to treat difficult-to-treat conditions including ovarian cancer and infectious diseases. The company's platforms instruct the immune system to generate targeted therapeutic responses.
0 investors